Technical analyst Manoj Sachdeva of Hem Securities has maintained 'buy' rating on Fortis Healthcare stock with a target of Rs 182.

According to analyst, the interested investors can buy the stock at Rs 169 with stop loss of Rs 165.

Mr. Sachdeva added that the said target can be achieved within 3-4 trading sessions.

Today, the stock of the company opened at Rs 168.40 on the Bombay Stock Exchange (BSE).

The share price has seen a 52-week high of Rs 187.50 and a low of Rs 104 on BSE.

Current EPS & P/E ratio stood at 2.70 and 62.76 respectively.

Fortis Healthcare recorded a 477%growth in its net profit for the three month period ended September 30.

The net profit of the healthcare group stood at Rs 74.8 crore as against Rs 12.8 crore in the like period of 2009.

The total income during the period under review grew by 88% to Rs 357.85 crore as against Rs 190.5 crore in the same period of 2009.

The healthcare provider said that it attained this strong growth on the back of performances shown by its facilities located at Noida, Mohali, Malar (Chennai) and Jaipur.

Moreover, Fortis Healthcare has inked a contract with two hospitals in Dubai and Tanzania to establish specialized medical facilities in the countries as part of its foreign growth plan.